Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $15.06.
IAS has been the topic of a number of research reports. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a research note on Friday, February 28th. Scotiabank started coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They issued a “sector perform” rating and a $12.00 price objective on the stock. Barclays reiterated an “equal weight” rating on shares of Integral Ad Science in a report on Friday, February 28th. Oppenheimer restated an “outperform” rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Morgan Stanley reiterated a “mixed” rating on shares of Integral Ad Science in a report on Monday, March 3rd.
Read Our Latest Stock Analysis on Integral Ad Science
Insider Buying and Selling
Hedge Funds Weigh In On Integral Ad Science
Several hedge funds and other institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Integral Ad Science by 4.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company’s stock valued at $433,000 after purchasing an additional 1,832 shares during the last quarter. Crestwood Capital Management L.P. boosted its stake in shares of Integral Ad Science by 0.3% in the 3rd quarter. Crestwood Capital Management L.P. now owns 650,738 shares of the company’s stock worth $7,034,000 after buying an additional 1,941 shares during the last quarter. Jennison Associates LLC grew its holdings in shares of Integral Ad Science by 3.3% in the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company’s stock valued at $663,000 after acquiring an additional 2,046 shares in the last quarter. Oppenheimer & Co. Inc. increased its position in shares of Integral Ad Science by 8.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company’s stock valued at $293,000 after acquiring an additional 2,069 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its holdings in Integral Ad Science by 7.4% during the fourth quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company’s stock worth $332,000 after acquiring an additional 2,188 shares during the period. Institutional investors and hedge funds own 95.78% of the company’s stock.
Integral Ad Science Trading Up 2.2 %
IAS opened at $9.10 on Tuesday. The firm has a 50 day simple moving average of $10.11 and a 200 day simple moving average of $10.61. Integral Ad Science has a fifty-two week low of $7.98 and a fifty-two week high of $13.62. The company has a market cap of $1.49 billion, a price-to-earnings ratio of 45.50, a price-to-earnings-growth ratio of 1.06 and a beta of 1.45. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last released its earnings results on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). The company had revenue of $153.00 million during the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.06 EPS. On average, sell-side analysts anticipate that Integral Ad Science will post 0.26 earnings per share for the current year.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading
- Five stocks we like better than Integral Ad Science
- Top Biotech Stocks: Exploring Innovation Opportunities
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Short Selling – The Pros and Cons
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Invest in Biotech Stocks
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.